A human interactome to prioritise drug discovery
Researchers create a network of interacting proteins – or interactome – to aid drug discovery.
2023
research-highlightsscience
Finding coronavirus’s helper proteins
A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Repurposing drugs for a pan-coronavirus treatment
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three pathogenic coronaviruses. They also found potential drugs that could be repurposed as COVID-19 treatments, and against emerging coronavirus strains in the…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical trials
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Identifying how potential COVID-19 drugs work
EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Drivers of evolution hidden in plain sight
A rapid, versatile mechanism that modifies proteins is revealed to be crucial for the evolutionary process
SCIENCE & TECHNOLOGY2016
sciencescience-technology
EMBL-EBI hosts the Cambridge New Therapeutics Forum
CamNTF hosts meetings around Cambridge, open to all scientists interested in new therapeutics
CONNECTIONS2016
connectionsevents
See data in a new light
3D printing, gaming, virtual reality and lenticular posters bring new perspectives to research
SCIENCE & TECHNOLOGY2016
sciencescience-technology
No results found